(-0.08%) 5 304.25 points
(-0.09%) 40 140 points
(-0.05%) 18 465 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.13%) $0.928
(0.31%) $10.88
(0.00%) $0.792
(-0.97%) $91.68
Live Chart Being Loaded With Signals
Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products in Europe, the United States, and internationally. It develops MOB-015, which has completed Phase III clinical trial for the treatment of nail fungus...
Stats | |
---|---|
Today's Volume | 620 330 |
Average Volume | 418 142 |
Market Cap | 631.93M |
EPS | SEK0 ( 2024-02-12 ) |
Next earnings date | ( SEK0 ) 2024-05-06 |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | -28.25 |
ATR14 | SEK0.215 (0.95%) |
Volume Correlation
Moberg Pharma AB (publ) Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Moberg Pharma AB (publ) Correlation - Currency/Commodity
Moberg Pharma AB (publ) Financials
Annual | 2023 |
Revenue: | SEK0 |
Gross Profit: | SEK-2.10M (0.00 %) |
EPS: | SEK-1.330 |
Q4 | 2023 |
Revenue: | SEK0 |
Gross Profit: | SEK-260 000 (0.00 %) |
EPS: | SEK-0.230 |
Q3 | 2023 |
Revenue: | SEK0 |
Gross Profit: | SEK-613 000 (0.00 %) |
EPS: | SEK-0.170 |
Q2 | 2023 |
Revenue: | SEK0 |
Gross Profit: | SEK-613 000 (0.00 %) |
EPS: | SEK-0.370 |
Financial Reports:
No articles found.
Moberg Pharma AB (publ)
Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products in Europe, the United States, and internationally. It develops MOB-015, which has completed Phase III clinical trial for the treatment of nail fungus. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is headquartered in Bromma, Sweden.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators